FindTrial
Sign In

Airway clearence with vacuum technology: the effectiveness of the Free Aspire system in patients with severe COPD: A pilot study

Airway clearence with vacuum technology: a pilot study on the effectiveness of the Free Aspire system in patients with severe COPD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16009518
Enrollment
Unknown
Registered
2016-10-20
Start date
2016-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstrucrive pulmonay disease (COPD)

Interventions

Treatment 1:FREE ASPIRE treatment
Treatment 2:PEP Treatment
Control Group:No treatment

Sponsors

ASL4 Chiavarese Liguria
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 81 Years

Inclusion criteria

Inclusion criteria: The following inclusion criteria were adapted: -presence of bronchial obstruction defined by anamnesis, clinical examination and chest auscultation; -pick cough expiratory flow (PCEF) =270 l/min; In the study group using Free Aspire were 10 patients. In the PEP group 10 patients treated with positive expiratory pressure.

Exclusion criteria

Exclusion criteria: pazients with tracheostomy,previous diagnosis of bronchial asthma, respiratory allergy or bronchiectasis or with a COPD exacerbation.

Design outcomes

Primary

MeasureTime frame
respiratory function parameters;—

Countries

Italy

Contacts

Public ContactAntonello Nicolini

Respiratory Diseases Unit

antonellonicolini@gmail.com+390185329145

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026